Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Leuk Lymphoma ; 64(1): 42-56, 2023 01.
Article in English | MEDLINE | ID: mdl-36270021

ABSTRACT

Chronic lymphocytic leukemia (CLL) is a disorder of mature malignant B cells with multiple elements of immune dysfunction. Infections are common in CLL patients due to complex immunodeficiency. Vaccines are used as preventative measures for common diseases including influenza, pneumococcus, tetanus/diphtheria and shingles in the general population. Vaccines are utilized to mitigate this risk, although there have been some concerns regarding the efficacy of vaccines in the CLL population due to the inherent complex immune dysfunction associated with the disease. In this review, we describe the clinical and laboratory indicators for efficacy of the vaccines in the CLL population (including COVID-19, influenza, pneumonia, herpes zoster, and tetanus) and discuss immunization recommendations for patients with CLL.


Subject(s)
COVID-19 , Herpes Zoster , Influenza, Human , Leukemia, Lymphocytic, Chronic, B-Cell , Tetanus , Vaccines , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/complications , Leukemia, Lymphocytic, Chronic, B-Cell/therapy , Tetanus/complications , Tetanus/prevention & control , COVID-19/complications , COVID-19/epidemiology , COVID-19/prevention & control , Vaccination , Herpes Zoster/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...